Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

HCA Healthcare Inc Stock Research

HCA

252.27USD-1.17(-0.46%)Market Closed
Watchlist

Market Summary

USD252.27-1.17
Market Closed
-0.46%

HCA Alerts

  • 2 major insider sales recently.

HCA Stock Price

HCA RSI Chart

HCA Valuation

Market Cap

68.9B

Price/Earnings (Trailing)

11.93

Price/Sales (Trailing)

1.11

EV/EBITDA

4.99

Price/Free Cashflow

13.96

HCA Price/Sales (Trailing)

HCA Profitability

EBT Margin

14.27%

Return on Equity

-7.7K%

Return on Assets

10.88%

Free Cashflow Yield

7.16%

HCA Fundamentals

HCA Revenue

Revenue (TTM)

61.9B

Revenue Y/Y

7.02%

Revenue Q/Q

1.73%

HCA Earnings

Earnings (TTM)

5.8B

Earnings Y/Y

3.29%

Earnings Q/Q

-12.47%

Price Action

52 Week Range

178.32304.86
(Low)(High)

Last 7 days

-1.6%

Last 30 days

-9.0%

Last 90 days

-14.6%

Trailing 12 Months

30%

HCA Financial Health

Current Ratio

1.23

Debt/Equity

-516.58

Debt/Cashflow

0.23

HCA Investor Care

Dividend Yield

0.92%

Dividend/Share (TTM)

2.32

Buy Backs (1Y)

6.70%

Diluted EPS (TTM)

20.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for HCA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-14
RUTHERFORD BILL B
gifted
-
-
90,000
cfo and evp
2023-08-14
Torres Kathryn A.
sold
-1,400,520
269
-5,204
svp-payer contracting & align.
2023-08-14
RUTHERFORD BILL B
gifted
-
-
-40,500
cfo and evp
2023-08-14
RUTHERFORD BILL B
gifted
-
-
-49,500
cfo and evp
2023-08-11
Cohen Jeffrey E.
sold
-405,000
270
-1,500
svp-government relations
2023-08-04
Marks Mike A
gifted
-
-
-205
svp-finance
2023-08-03
Marks Mike A
gifted
-
-
8,343
svp-finance
2023-08-03
Marks Mike A
gifted
-
-
-8,343
svp-finance
2023-08-03
Whalen Kathleen M
sold
-787,320
270
-2,916
svp & chief ethics officer
2023-08-02
RUTHERFORD BILL B
gifted
-
-
-49,500
cfo and evp

1–10 of 50

Which funds bought or sold HCA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-21
Jefferies Group LLC
added
88.67
4,828,230
9,368,880
0.08%
2023-09-21
Halpern Financial, Inc.
new
-
28,831
28,831
0.01%
2023-09-20
BARCLAYS PLC
added
135
85,095,000
134,746,000
0.09%
2023-09-20
Mondrian Investment Partners LTD
reduced
-10.05
4,678,210
137,307,000
2.74%
2023-09-14
IMS Capital Management
new
-
203,332
203,332
0.11%
2023-09-12
Farther Finance Advisors, LLC
added
2.61
14,612
95,305
0.02%
2023-09-07
ST GERMAIN D J CO INC
sold off
-
-
-
-%
2023-09-05
Westshore Wealth, LLC
reduced
-6.00
40,277
532,304
0.27%
2023-09-01
Manhattan West Asset Management, LLC
reduced
-0.95
34,999
284,968
0.11%
2023-08-30
Western Wealth Management, LLC
added
0.85
139,121
1,004,830
0.09%

1–10 of 46

Latest Funds Activity

Are funds buying HCA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own HCA
No. of Funds

Schedule 13G FIlings of HCA Healthcare

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
frist thomas f jr
24.5%
69,391,032
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
2.5%
7,039,050
SC 13G/A
Feb 14, 2023
hercules holding ii
24.4%
68,912,077
SC 13G/A
Feb 09, 2023
vanguard group inc
6.35%
17,946,718
SC 13G/A
Feb 06, 2023
wellington management group llp
5.08%
14,369,349
SC 13G
Feb 01, 2023
blackrock inc.
5.2%
14,839,215
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
6.7%
21,128,934
SC 13G/A
Feb 14, 2022
hercules holding ii
22.2%
68,912,077
SC 13G/A
Feb 14, 2022
frist thomas f jr
22.3%
69,301,932
SC 13G/A
Feb 10, 2022
vanguard group inc
6.09%
18,931,643
SC 13G/A

Recent SEC filings of HCA Healthcare

View All Filings
Date Filed Form Type Document
Aug 28, 2023
S-8
Employee Benefits Plan
Aug 16, 2023
4
Insider Trading
Aug 16, 2023
4
Insider Trading
Aug 15, 2023
4
Insider Trading
Aug 14, 2023
144
Notice of Insider Sale Intent
Aug 11, 2023
144
Notice of Insider Sale Intent
Aug 07, 2023
4
Insider Trading
Aug 07, 2023
4
Insider Trading
Aug 04, 2023
4
Insider Trading
Aug 03, 2023
4
Insider Trading

HCA Fair Value

Loading...

Peers (Alternatives to HCA Healthcare)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
68.9B
61.9B
-8.98% 30.00%
11.93
1.11
3.02% -11.37%
18.2B
14.1B
-4.55% -3.42%
21.91
1.29
-5.68% -58.27%
13.8B
9.5B
-7.45% 1.06%
17.42
1.46
-10.34% -46.50%
MID-CAP
9.0B
11.7B
-3.28% 12.82%
19.26
0.77
0.96% -43.93%
8.9B
13.8B
-2.67% 35.75%
12.86
0.65
5.76% -10.75%
7.0B
4.6B
0.36% 46.39%
22.31
1.53
9.56% -4.24%
6.9B
19.9B
-9.81% 26.31%
6.09
0.35
3.98% -22.32%
3.8B
2.7B
-12.50% 20.55%
-69.83
1.43
11.78% -86.30%
3.3B
6.5B
-8.71% 10.65%
16.25
0.51
3.35% -11.85%
SMALL-CAP
1.9B
1.5B
-12.60% 56.43%
-144.8
1.22
12.20% -155.34%
1.4B
999.1M
-5.28% -6.03%
25.82
1.39
10.42% 21.37%
803.8M
3.0B
0.71% -13.03%
-7.8
0.27
11.66% -12.20%
380.3M
12.4B
-15.50% 8.59%
1.34
0.03
-0.02% 847.37%
6.1M
46.8M
-7.45% -15.53%
-2.24
0.13
12.07% -154.21%

HCA Healthcare News

MarketBeat
Pacer Advisors Inc. Has $4.48 Million Stock Holdings in HCA ....
MarketBeat,
15 hours ago
HCA Healthcare Today
Mountain Xpress
HCA Healthcare Today
HCA Healthcare Today

Returns for HCA

Cumulative Returns on HCA

20.3%


10-Year Cumulative Returns

19.4%


7-Year Cumulative Returns

14.4%


5-Year Cumulative Returns

28.6%


3-Year Cumulative Returns

Risks for HCA

What is the probability of a big loss on HCA?

46.5%


Probability that HCA Healthcare stock will be more than 20% underwater in next one year

36.1%


Probability that HCA Healthcare stock will be more than 30% underwater in next one year.

18.5%


Probability that HCA Healthcare stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HCA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if HCA Healthcare was unfortunately bought at previous high price.

Drawdowns

Financials for HCA Healthcare

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.7%61,92060,87960,23359,80060,10559,72058,75257,98156,01652,64951,53350,76350,14651,68051,33650,08748,84447,77146,67745,96545,210
EBITDA-100.0%-13,49313,29012,49713,86914,15214,25213,65711,45310,8779,7359,3579,3649,0369,664------
EBITDA Margin-100.0%-0.22*0.22*0.21*0.23*0.24*0.24*0.24*0.20*0.21*0.19*0.18*0.19*0.17*0.19*------
Interest Expenses2.8%1,8631,8121,7411,6861,6381,5901,5661,5511,5381,5401,5841,6391,7021,7911,8241,8321,8261,7851,7551,7421,727
Earnings Before Taxes0.6%8,7378,6888,5807,8649,3179,6749,8339,3197,1506,5935,4304,9654,9564,5945,2445,1265,2165,2565,3355,2234,932
EBT Margin-100.0%-0.14*0.14*0.13*0.16*0.16*0.17*0.16*0.13*0.13*0.11*0.10*0.10*0.09*0.10*------
Net Income0.7%5,7715,7335,6435,3766,5116,8066,9566,5684,9674,5963,7543,3993,3433,0473,5053,4983,6453,6823,7873,1972,864
Net Income Margin-100.0%-0.09*0.09*0.09*0.11*0.11*0.12*0.11*0.09*0.09*0.07*0.07*0.07*0.06*0.07*------
Free Cashflow-100.0%-4,2494,1274,1743,6734,5325,382-2006407,2096,39711,95910,7183,7733,444------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets1.7%53,59452,71152,43851,48451,58452,20850,74249,56248,16447,27747,49051,01648,70945,42145,05843,91245,44943,37939,20738,04437,742
  Current Assets2.6%13,88813,54113,64313,48113,93715,00613,54213,24812,47512,03612,33316,26614,03111,01611,19610,76912,86911,10810,21310,01010,394
    Cash Equivalents2.4%8628429089998582,3711,4511,0271,1201,0301,7936,5884,6387316215592,430531502578868
  Inventory-1.7%2,0502,0852,0682,0092,0432,0031,9862,0192,0272,0682,0251,9501,8341,9531,8491,7691,8261,7781,7321,6341,636
  Net PPE2.3%26,64426,05325,57524,97824,58724,22824,06323,54723,47123,18823,19922,94123,07122,98522,71522,00221,46721,12819,75719,04118,544
  Current Liabilities4.7%11,54511,0289,9029,7848,99910,5189,5829,6248,6158,6428,70414,37912,8567,0197,7577,1248,96110,5317,5696,2317,625
    LT Debt, Current0.7%2,3952,3783702182461,4862372502532342091721631621451482,0733,7967881911,692
    LT Debt, Non Current0.2%36,53736,47837,71437,49238,65736,21034,34232,04932,31930,83830,79530,79230,77934,69933,57734,09734,12031,01932,03332,91631,500
Shareholder's Equity98.7%461232-73.00-778-1,1424141,4891,8251,7902,4822,8921,299568--------
  Retained Earnings8.8%-1,850-2,028-2,280-2,781-3,168-1,589-532-206-121735777-647-1,315-2,394-2,351-3,107-3,474-3,983-4,572-5,342-5,731
  Additional Paid-In Capital-----------29418588.00--------
Accumulated Depreciation2.1%30,02329,41029,18228,75228,22927,81427,28727,14827,22726,68926,11825,83425,41324,87624,52024,29323,90223,45523,20822,93722,598
Shares Outstanding-1.1%273276277284293302305318328338339338338338338341342343343346349
Minority Interest1.4%2,7642,7272,6942,5922,5382,4472,4222,5202,3832,2352,3202,2732,3542,2592,2432,1182,1322,0992,0321,8751,864
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations9.4%9,8258,9808,5228,4387,6958,3168,9592,9333,3739,8459,23215,32014,7298,0037,6027,2726,8676,4526,7616,3205,607
  Share Based Compensation-8.7%303332341357385429440474440377362313337367347327292270268279264
Cashflow From Investing-1.4%-3,747-3,695-3,389-4,310-3,124-2,839-2,643-1,839-3,009-2,897-3,393-3,828-4,560-4,700-5,720-5,661-5,699-5,731-3,901-3,722-4,003
Cashflow From Financing10.7%-6,078-6,806-5,656-4,124-4,810-4,126-6,655-6,665-3,907-6,672-4,677-5,471-7,957-3,096-1,771-1,622403-1,248-3,075-2,727-1,435
  Dividend Payments0.6%655651653645636632624476325170153289425561550535520505487488490
  Buy Backs-30.6%3,9905,7487,0007,5539,1848,7898,2156,1433,8141,5274417139521,1941,0311,0941,1571,3851,5301,7711,978

HCA Income Statement

2023-06-30
Condensed Consolidated Income Statements (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenues$ 15,861$ 14,820$ 31,452$ 29,765
Salaries and benefits7,2776,79214,36113,731
Supplies2,4782,3014,9014,622
Other operating expenses3,0432,6935,9375,445
Equity in losses (earnings) of affiliates7(8)25(19)
Depreciation and amortization7637381,5191,470
Interest expense485434964842
Losses (gains) on sales of facilities(1)321422
Losses on retirement of debt078078
Total expenses including equity in earnings of affiliates14,05213,06027,72126,191
Income before income taxes1,8091,7603,7313,574
Provision for income taxes397381776730
Net income1,4121,3792,9552,844
Net income attributable to noncontrolling interests219224399416
Net income attributable to HCA Healthcare, Inc.$ 1,193$ 1,155$ 2,556$ 2,428
Per share data:    
Basic earnings$ 4.35$ 3.95$ 9.27$ 8.16
Diluted earnings$ 4.29$ 3.9$ 9.14$ 8.05
Shares used in earnings per share calculations (in millions):    
Basic274,494292,527275,695297,459
Diluted278,198296,061279,573301,690

HCA Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 862$ 908
Accounts receivable8,7138,891
Inventories2,0502,068
Other2,2631,776
Total current assets13,88813,643
Property and equipment, at cost56,66754,757
Accumulated depreciation(30,023)(29,182)
Property and equipment, net26,64425,575
Investments of insurance subsidiaries384381
Investments in and advances to affiliates731823
Goodwill and other intangible assets9,6419,653
Right-of-use operating lease assets2,1102,065
Other196298
Total assets53,59452,438
Current liabilities:  
Accounts payable3,8234,239
Accrued salaries1,7761,712
Other accrued expenses3,5513,581
Long-term debt due within one year2,395370
Total current liabilities11,5459,902
Long-term debt, less debt issuance costs and discounts of $349 and $30136,53737,714
Professional liability risks1,5541,528
Right-of-use operating lease obligations1,8061,752
Income taxes and other liabilities1,6911,615
Stockholders' equity (deficit):  
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 272,931,700 shares - 2023 and 277,378,300 shares - 202233
Accumulated other comprehensive loss(456)(490)
Retained deficit(1,850)(2,280)
Stockholders' deficit attributable to HCA Healthcare, Inc.(2,303)(2,767)
Noncontrolling interests2,7642,694
Total stockholders' equity461(73)
Total liabilities and stockholders' equity$ 53,594$ 52,438
Samuel N. Hazen
65535
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.